INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

52 hedge funds and large institutions have $203M invested in Inozyme Pharma in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 4 closing their positions.

Holders
52
Holders Change
+2
Holders Change %
+4%
% of All Funds
0.91%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
6
Increased
18
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
1
Suvretta Capital Management
New York
$11.4M
2
MB
2
MPM BioImpact
Massachusetts
$3.72M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$3.85M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.08M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$17M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
NHAS
2
Novo Holdings A/S
Denmark
$0
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$4.23M
4
BCM
4
Burrage Capital Management
Massachusetts
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$1.1M
Name Market Value Shares Shares
Change 		Shares
Change %
NMC
1
NEA Management Company
Maryland
$28.3M 2,444,379 – –
DM
2
Deerfield Management
New York
$27.2M 2,344,786 +165,801 +8%
SI
3
Sofinnova Investments
California
$23.5M 2,028,308 – –
PBPIA
4
Pivotal bioVenture Partners Investment Advisor
California
$18.4M 1,591,154 – –
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$17M 1,467,828 +179,156 +14%
SCM
6
Suvretta Capital Management
New York
$11.4M 986,400 +621,228 +170%
CA
7
CHI Advisors
New York
$10.7M 920,264 -7,000 -0.8%
BlackRock
8
BlackRock
New York
$10.4M 900,719 +846 +0.1%
RSCM
9
Rock Springs Capital Management
Maryland
$9.85M 850,015 +9,743 +1%
Vanguard Group
10
Vanguard Group
Pennsylvania
$7.08M 611,185 +275,899 +82%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$7.06M 609,380 – –
Wellington Management Group
12
Wellington Management Group
Massachusetts
$4.23M 364,600 -364,954 -50%
JPMorgan Chase & Co
13
JPMorgan Chase & Co
New York
$3.85M 331,891 +315,232 +1,892%
MB
14
MPM BioImpact
Massachusetts
$3.72M 320,724 +320,724 New
O
15
OrbiMed
New York
$3.41M 294,000 +105,296 +56%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.3M 198,624 +18,952 +11%
State Street
17
State Street
Massachusetts
$2.18M 188,267 +18,378 +11%
CCM
18
CAAS Capital Management
New York
$1.57M 135,398 +135,398 New
Northern Trust
19
Northern Trust
Illinois
$1.35M 116,101 -4,642 -4%
Russell Investments Group
20
Russell Investments Group
United Kingdom
$1.34M 115,516 +113,015 +4,519%
BBA
21
Baker Bros. Advisors
New York
$1.24M 106,999 – –
Citadel Advisors
22
Citadel Advisors
Florida
$1.1M 94,466 -76,600 -45%
LCM
23
Laurion Capital Management
New York
$819K 70,700 +70,700 New
Commonwealth Equity Services
24
Commonwealth Equity Services
Massachusetts
$762K 65,781 – –
Nuveen Asset Management
25
Nuveen Asset Management
Illinois
$565K 47,662 +268 +0.6%
1
2 3